Benchmarking and visualising the knowledge base of pharmaceutical firms (1995-2009)

Perianes-Rodríguez, Antonio and O'Hare, Alice and Hopkins, Michael-M. and Nightingale, Paul and Rafols, Ismael Benchmarking and visualising the knowledge base of pharmaceutical firms (1995-2009)., 2011 . In 13Th International Conference of the International Society for Scientometrics and Informetrics, Durban (South Africa), 04-07, July, 2011. [Conference paper]


Download (7MB) | Preview

English abstract

The rise of biotechnology in the 1970s ushered in a change in innovation strategies in the pharmaceutical industry. The vertically-integrated company become more reliant on a distributed innovation structure in which large corporations integrate the knowledge generated by a network of actors, including small biotechnology firms and public research organisations. In this context, it is important for the players in the network to benchmark the knowledge base of pharmaceutical firms against their competitors in the industry, as well as against possible collaborators. In this paper we present a suite of interactive visualization techniques that help understand the relative positions of pharmaceutical firms, collaborators and past or prospective mergers and acquisitions.

Item type: Conference paper
Keywords: Information visualisation, network analysis, Pharmaceutical industry, science maps, scientific collaboration, co-citation analysis.
Subjects: B. Information use and sociology of information > BB. Bibliometric methods
Depositing user: Antonio Perianes-Rodríguez
Date deposited: 01 Mar 2012
Last modified: 02 Oct 2014 12:21


Hopkins, M.M., Martin, P.A., Nightingale, P., Kraft, A. & Mahdi, S. (2007). The Myth of the Biotech Revolution: An assessment of technological, clinical and organisational change. Research Policy, 36 (4), 566-589.

McKelvey, M., Orsenigo, L. & Pammolli, F. (2004). Pharmaceutical analized through the lens of a sectoral innovation system. In Malerba, F. (ed.), Sectoral Systems of Innovation. Cambridge: Cambridge University Press, pp. 73-120.

Morgan Stanley. (2010). Exit research and create value. New York: Morgan Stanley Research Pharmaceuticals.

Munos, B. (2009). Lessons from 60 years of Pharmaceutical Innovation. Nature Reviews Drug Discovery, 8, 959-968.

Nightingale, P. & Martin, P. (2004). The Myth of the Biotech Revolution. Trends in Biotechnology, 22, 564-569.

Perianes-Rodríguez, A., Olmeda-Gómez, C. & Moya-Anegón, F. (2010). Detecting and Visualizing Research Groups in Co-authorship Networks. Scientometrics, 82 (2), 307-319.

Rafols, I., Porter, A. & Leydesdorff, L. (2010a). Science Overlay Maps: A new tool for Research Policy and Library Management. Journal of the American Society for Information Science and Technology, 61 (9), 1871-1887.

Rafols, I., O'Hare, A., Perianes, A., Hopkins, M.M. & Nightingale, P. (2010b). Collaborative practices and technological trajectories in large pharmaceutical firms. International Conference of Tentative Governance in Emerging Science and Technology (pp. 93-95). Enschede: Twente University.

Tijssen, R.J.W. (2009). Internationalisation of pharmaceutical R&D: how globalised are Europe's largest multinational companies?, Technology Analysis & Strategic Management, 21(7), 859-879.

Verspagen, B. (2007) Mapping technological trajectories as patent citation networks: a study on the history of fuel cell research. Advances in Complex Systems, 10 (1), 93-115.


Downloads per month over past year

Actions (login required)

View Item View Item